The Global Recombinant Proteins Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Scope of the Report:
Increasing research and development expenditure on biologic drugs is expected to boost demand for recombinant proteins for research purposes
The global Recombinant Proteins market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recombinant Proteins.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Recombinant Proteins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Recombinant Proteins market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Crown Bioscience, Inc
- ProSpec Tany TechnoGene, Ltd.
- BPS Bioscience, Inc.
- Sigma Aldrich Company Ltd.
- Novoprotein Scientific
- PeproTech, Inc.
- Feldan Bio, Inc.
- BioVision, Inc.
- HumanZyme, Inc.
- GenScript Biotech Corporation
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Hormones
- Growth Factors
- Cytokines
- Plasma Protein Factor
- Recombinant Metabolic Enzymes
- Immune Checkpoint Regulators
- Others
Market Segment by Applications, can be divided into
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
- Others